RSV – a common but perhaps not well known virus – can infect anyone, but very young children and the elderly are at greatest risk of developing severe disease
Sponsored article

What exactly is RSV (respiratory syncytial virus) and why haven’t I heard of it?

It may be surprising that most children are infected with RSV before the age of 2 years, and that RSV infection can occur more than once at any age. So you probably already had RSV and the virus was interpreted as the common cold. That’s why most of us have never heard of him before. In fact, however, not everyone is so lucky …

Although the symptoms often resemble a cold, high-risk people may become seriously ill with pneumonia or bronchiolitis (inflammation of the small airways in the lungs). The high-risk group includes very young infants, premature children and older adults, and other people with a weak immune system.

RSV is a highly contagious virus that is transmitted by air, for example when an infected person coughs or sneezes, and can be spread easily through casual contact with other people. This high infectivity of the virus means that it can spread rapidly between vulnerable children and the elderly.

What actions are being taken in this connection?

Synexus, a leading clinical research organization, is actively recruiting healthy volunteers who would like to contribute to the advancement of research to help protect others from respiratory syncytial virus (RSV).

Eligible participants can receive study-related care from qualified doctors and nurses, including specialist advice and support, throughout the study. Synexus also offers routine health check-ups including height, weight, body mass index (BMI), blood pressure, and blood cholesterol.

One participant said: “I volunteered after I heard an announcement on the radio about a Synexus hypertension study. During the participation, the staff and the quality of care at the center were really outstanding. I have never participated in a clinical trial before, but my positive experiences have led me to apply for another trial in which I am currently an active participant. “

To find out if you qualify for a Synexus clinical trial and may be receiving an investigational drug against RSV, call 22 262 92 42 today or visit clinic.

Sponsored article

Leave a Reply